Home » Oxford Expression Tech, Eden Biodesign Form Co-marketing Pact

Oxford Expression Tech, Eden Biodesign Form Co-marketing Pact

Feb 02, 2009

NEW YORK (GenomeWeb News) — Oxford Expression Technologies and Eden Biodesign have struck a co-marketing agreement to serve pharmaceutical researchers involved in protein expression.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Scan

Who Are You?

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

'Problematic'

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Republicans Take on Peer Review

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

This Week in Science

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.

What's Popular?

In Proteomics & Protein Research

  1. Hopkins-Led Team IDs Autoantibody Panel for Early Detection of Lung Cancer

    Premium

  2. Groningen Study Pushes Nanopore Protein Analysis Closer to Feasibility

    Premium

  3. Tech Advances Could Help Unlock Plasma Proteome's Biomarker Potential

    Premium

  4. Protein Interaction Data Provides Window Into Mutation Significance

    Premium

  5. Moffitt Team Uses Proteomic Profiling to ID New Ceritinib Targets in Lung Cancer

    Premium

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.